Substances / Cross

Weed and Medications: What Changes When You Quit

By RethinkTHC Research Team|13 min read|February 23, 2026

Substances / Cross

50%

Cannabis inhibits the liver enzyme responsible for processing 50% of all prescription drugs, so quitting can shift how your body handles SSRIs, blood thinners, and other medications within one to three weeks.

Yamaori et al. (2011)

Yamaori et al. (2011)

Infographic showing cannabis inhibits liver enzyme CYP3A4 that processes 50 percent of prescription medicationsView as image

If you take prescription medications and you are planning to quit cannabis, there is something important that rarely gets discussed: quitting weed medication interactions. Cannabis does not just affect your brain. It also affects your liver, specifically the enzyme system your body uses to break down most prescription drugs. When you stop using cannabis, those liver enzymes shift back to their normal activity levels, and that shift can change how your medications work.

This is not a reason to avoid quitting. It is a reason to loop your doctor in before you do. If you are weighing the tradeoffs, the guide on proven medical benefits of cannabis can help you understand what the evidence does and does not support about therapeutic use. Understanding the basics of how medication interactions work puts you in a much better position to quit safely and avoid unnecessary side effects.

Key Takeaways

  • Cannabis — especially CBD — slows down liver enzymes (the CYP450 system) that break down many common medications, so your prescription doses may have been set while your body was also processing cannabis
  • When you quit, those enzymes gradually return to normal speed, which can change how fast your body processes medications like SSRIs, blood thinners, blood pressure drugs, and benzodiazepines
  • Enzyme activity typically normalizes within one to three weeks after stopping cannabis, but the timeline varies by person
  • Tell your prescribing doctor before you quit so they can monitor your medication levels and adjust doses if needed
  • This article is educational and does not replace medical advice from your prescriber about your specific quitting weed medication interactions
  • CYP3A4 alone breaks down roughly 50% of all prescription medications, making it the single most important enzyme affected by cannabis use and cessation

How Cannabis Affects Your Liver Enzymes

Your liver uses a family of enzymes called the cytochrome P450 system (CYP450) to metabolize, or break down, most of the drugs you take. Think of these enzymes as a processing line. When a medication enters your body, CYP450 enzymes convert it into forms your body can use and eventually eliminate.

Cannabis, particularly CBD but also THC to a lesser degree, inhibits several of these enzymes. The two most affected are CYP3A4 and CYP2C19. Yamaori and colleagues, in a 2011 study published in Biochemical Pharmacology, demonstrated that CBD is a potent inhibitor of multiple CYP450 enzymes, with CYP3A4 being especially sensitive.

In practical terms, this means that while you are using cannabis regularly, some of your medications may be broken down more slowly than they otherwise would be. More of the drug stays in your system for longer. Your doctor may have unknowingly set your dose based on a body where cannabis was already slowing the processing line.

CYP3A4 alone is responsible for metabolizing roughly 50% of all prescription medications. CYP2C19 handles another significant share. When these enzymes are partially inhibited by cannabis use, the effects ripple across your entire medication profile.

What Happens When You Quit

When you stop using cannabis, the inhibition lifts. Your CYP450 enzymes gradually return to their baseline activity. The processing line speeds back up.

This means medications that were accumulating at slightly higher levels may now be cleared faster. In some cases, a dose that was working well while you were using cannabis may become less effective after you quit, because your body is now metabolizing it at its normal, faster rate.

The reverse is also possible for a smaller number of medications. Cannabis can induce (speed up) certain enzymes in some individuals, which means stopping could temporarily slow the processing of those particular drugs. The direction of the change depends on the specific medication, your genetics, and your pattern of cannabis use.

Anderson and Chan, in a 2016 review published in Clinical Pharmacokinetics, noted that the clinical significance of cannabinoid-drug interactions is likely underrecognized because so few patients disclose cannabis use to their prescribers.[1]

Which Medications Are Most Affected

Substances / Cross

Medications Affected When You Quit Cannabis

CYP3A4 processes ~50% of all prescriptions. Cannabis (especially CBD) slows this enzyme. When you quit, it speeds back up — changing how fast your body clears medications.

SSRIs / AntidepressantsCYP2C19 + CYP3A4

Zoloft, Lexapro, Prozac

Dose may become less effective after quitting

Blood thinnersCYP2C19 + CYP3A4

Warfarin

INR may shift — requires monitoring

Blood pressureCYP3A4

Amlodipine, diltiazem

May need dose adjustment

BenzodiazepinesCYP3A4

Xanax, Valium

Faster metabolism → reduced effectiveness

Birth controlCYP3A4

Oral contraceptives

Possible efficacy change

StatinsCYP3A4

Atorvastatin

Cholesterol management may shift

Action: Tell your prescribing doctor before you quit cannabis. Enzyme activity normalizes in 1–3 weeks — they may need to adjust your doses.

Source: Yamaori et al. (2011); Anderson & Chan (2016)Medications Affected When You Quit Cannabis

Not all medications pass through the same enzymes. Here are the categories most likely to be affected when you quit cannabis, based on their reliance on CYP3A4 and CYP2C19 for metabolism.

SSRIs and Other Antidepressants

Several commonly prescribed antidepressants are metabolized by CYP450 enzymes that cannabis inhibits. Sertraline (Zoloft), citalopram (Celexa), and escitalopram (Lexapro) are processed partly through CYP2C19. Fluoxetine (Prozac) involves CYP3A4 among other pathways.

While you were using cannabis, these medications may have been present at slightly higher levels in your blood. After quitting, you might notice a subtle decrease in their effectiveness as your enzyme activity normalizes. If you are already navigating the overlap between cannabis withdrawal and anxiety medication, this is another reason to keep your prescriber informed. For a deeper look at that intersection, see quitting weed when you are on anxiety medication. If you are actively combining THC with an SSRI or other antidepressant, the THC and SSRIs guide covers the specific risks of that combination.

Blood Thinners

Warfarin, one of the most commonly prescribed blood thinners, is metabolized by CYP2C19 and CYP3A4. Changes in enzyme activity can shift your INR (international normalized ratio, a measure of how quickly your blood clots). A dose that kept your INR in range while you were using cannabis might produce different results once cannabis is out of the picture. If you take warfarin, this is a conversation to have with your doctor before you quit, not after.

Blood Pressure Medications

Calcium channel blockers like amlodipine and diltiazem rely heavily on CYP3A4 for metabolism. So do some beta blockers. If your blood pressure has been well-controlled on a certain dose while using cannabis, quitting could shift the balance enough to require monitoring and possible adjustment. For more detail on how THC specifically interacts with blood pressure drugs, see THC and blood pressure medication.

Benzodiazepines

Alprazolam (Xanax), midazolam, and diazepam (Valium) are all metabolized through CYP3A4. If you take benzodiazepines and quit cannabis, your body may begin processing these medications faster, potentially reducing their effectiveness. Never adjust benzodiazepine doses on your own. Changes to benzodiazepine dosing require medical supervision because of the risk of withdrawal and rebound effects. The cannabis withdrawal complete guide covers the broader withdrawal picture, but benzodiazepine adjustments are strictly a conversation with your prescriber. For a closer look at the risks of combining THC with benzodiazepines while you are still using, see THC and benzodiazepines.

Hormonal Birth Control

Some oral contraceptives are metabolized by CYP3A4. In theory, changes in enzyme activity after quitting cannabis could alter how effectively your body processes these medications. If you rely on hormonal birth control, mention your cannabis quit to your prescriber so they can evaluate whether any monitoring is appropriate.

Other Medications to Watch

Statins (cholesterol medications like atorvastatin), certain immunosuppressants (tacrolimus, cyclosporine), and some anti-seizure medications also pass through CYP3A4. If you take any of these, your prescriber should be part of your quit plan.

The same enzyme pathway is relevant for several other common medication categories. If you take antipsychotic medications, diabetes medication, opioid painkillers, muscle relaxers, ibuprofen or other NSAIDs, antibiotics, or stimulants like Adderall, the interaction picture has its own nuances worth understanding before you quit.

If you have a scheduled surgery, the interaction between cannabis and anesthesia adds another layer of complexity — see quitting weed before surgery for what your surgical team needs to know.

The Timeline for Enzyme Normalization

How quickly do your liver enzymes return to baseline after you stop cannabis? The answer depends on several factors, including how much and how often you were using, your individual genetics, and your overall liver function.

For most people, the inhibitory effects of cannabis on CYP450 enzymes begin to diminish within days of the last use and are largely resolved within one to three weeks. This timeline roughly parallels the period when THC and its metabolites are being cleared from your system. CBD, which is the stronger enzyme inhibitor, has a shorter half-life than THC but may still exert effects for several days after the last dose.

This means the window that requires the most attention is the first two to four weeks after quitting. This is the same period when cannabis withdrawal symptoms are at their peak, which makes communication with your healthcare provider doubly important.

Tell Your Doctor Before You Quit

This is the single most important takeaway. If you take any prescription medications and you are planning to stop using cannabis, tell your prescribing doctor before you quit.

The conversation does not need to be complicated. Something like: "I have been using cannabis regularly, and I am going to stop. I know it can affect how my liver processes medications, and I wanted you to be aware so we can keep an eye on things."

Your doctor can then decide whether any monitoring is needed. For some medications, like warfarin, they may want to check levels more frequently during the first few weeks. For others, they may simply ask you to report any changes in how you feel.

What you should not do is adjust any medication doses on your own. The interactions described in this article are real, but they vary significantly between individuals. Your prescriber has the clinical context to make safe adjustments. You do not.

A Note on CBD Products During Withdrawal

If you are considering using CBD to manage withdrawal symptoms, be aware that CBD is actually the stronger CYP450 inhibitor compared to THC. Adding CBD supplements during your quit could maintain the enzyme inhibition you are trying to resolve, potentially complicating your medication picture further. For the full evidence on CBD during withdrawal, see does CBD help with weed withdrawal. If you are also looking at other supplements, the supplements for weed withdrawal guide is worth reviewing with this enzyme context in mind.

When to Seek Professional Help

Talk to your prescriber before quitting cannabis if you take any regular medications. Seek immediate medical attention if you experience unusual bleeding, significant changes in blood pressure, severe dizziness, or any sudden worsening of symptoms after quitting.

If you are also dealing with withdrawal symptoms that feel unmanageable, or if you want structured support for quitting, SAMHSA's National Helpline is available at 1-800-662-4357. It is free, confidential, and available 24/7.

For ongoing anxiety during the quit process, working with a therapist who understands both cannabis use and medication management can make a meaningful difference. The article on therapy for quitting weed and anxiety covers how to find the right fit.

You Are Making a Smart Move

Quitting cannabis when you take prescription medications requires a little more coordination than quitting without them. But the fact that you are thinking about drug interactions before you quit, rather than wondering what went wrong after, means you are approaching this with exactly the right mindset.

Your liver enzymes will normalize. Your medications can be monitored and adjusted. The transition period is temporary and manageable with professional guidance. The goal is not to make this process scary. It is to make it smooth.

The Bottom Line

Cannabis, particularly CBD, inhibits the CYP450 liver enzyme system responsible for metabolizing most prescription medications. Yamaori et al. (2011, Biochemical Pharmacology) demonstrated that CBD is a potent inhibitor of multiple CYP450 enzymes, especially CYP3A4 (which metabolizes roughly 50% of all prescriptions) and CYP2C19. Anderson and Chan (2016, Clinical Pharmacokinetics) noted that clinical significance of cannabinoid-drug interactions is likely underrecognized due to low patient disclosure rates. During active cannabis use, enzyme inhibition causes slower medication processing and higher drug levels. After quitting, enzymes normalize within 1-3 weeks, potentially reducing medication effectiveness as processing speeds return to baseline. Most affected medication categories: SSRIs (sertraline, citalopram via CYP2C19), blood thinners (warfarin via CYP2C19/CYP3A4 — INR shifts require monitoring), blood pressure medications (calcium channel blockers via CYP3A4), benzodiazepines (alprazolam, diazepam via CYP3A4), hormonal birth control (CYP3A4), and statins. CBD is the stronger enzyme inhibitor, so using CBD during withdrawal can maintain the enzyme changes. The critical action: inform your prescriber before quitting so medication levels can be monitored during the 2-4 week normalization window.

Frequently Asked Questions

Sources & References

  1. 1RTHC-01092·Anderson, Gail D et al. (2016). How Cannabis, Tobacco, and Smoking Cessation Products Interact With Other Medications.” Clinical pharmacokinetics.Study breakdown →PubMed →

Research Behind This Article

Showing the 8 most relevant studies from our research database.

Strong EvidenceMeta-Analysis

Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.

Murri, Martino Belvederi · 2026

Cannabis use was associated with higher anti-inflammatory biomarkers (SMD = 0.298, PD = 99%) and pro-inflammatory biomarkers (SMD = 0.166, PD = 100%).

Strong EvidenceMeta-Analysis

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis.

Weidberg, Sara · 2026

CBD use was significantly more prevalent in North America than Europe across all time periods.

Strong EvidenceMeta-Analysis

The Pleiotropic Influence of Cannabidiol and Tetrahydrocannabinol on Inflammatory Biomarkers: A Systematic Review and Meta-Analytical Synthesis.

Candeloro, Bruno Moreira · 2025

Pooled estimates showed trivial and imprecise effects: IL-6 (SMD -0.17, p=0.41), IL-8 (SMD -0.30, p=0.06), IL-10 (SMD -0.10, p=0.79), and TNF-alpha (SMD -0.09, p=0.62).

Strong EvidenceMeta-Analysis

Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.

Chou, Roger · 2025

THC:CBD oral spray: small pain decrease (MD -0.54/10); high THC: small decrease (MD -0.78/10); CBD alone: no benefit (moderate SOE); THC products caused large dizziness increase (RR 3.57) and sedation increase (RR 5.04)..

Strong EvidenceMeta-Analysis

Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies.

Ding, Cheng · 2024

Across 10 studies with 17,981,628 participants, CUD was associated with significantly higher odds of medical complications (OR 1.33), implant-related complications (OR 1.75), cardiac complications (OR 1.95), stroke (OR 2.06), infections (OR 1.68), periprosthetic fracture (OR 1.42), mechanical loosening (OR 1.54), and dislocation (OR 1.88).

Strong EvidenceMeta-Analysis

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.

Bilbao, Ainhoa · 2022

CBD showed high-grade evidence for epilepsy (SMD -0.5) and moderate-grade for Parkinsonism (SMD -0.41).

Strong EvidenceMeta-Analysis

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.

Silvinato, Antônio · 2022

CBD compared to placebo reduced seizure frequency by 33%, increased 50% seizure reduction by 20%, increased seizure freedom by 3%, and improved caregiver-assessed clinical impression by 21% in patients with refractory epilepsy..

Strong EvidenceMeta-Analysis

Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.

Gunning, Boudewijn · 2021

CBD reduced primary seizure frequency versus placebo in LGS (treatment ratio 0.70) and Dravet syndrome (0.71) in the overall population.